Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against U.S. Physical Therapy, Inc. Oklahoma City, OK (April 17, 2017) – On March 31, 2017, a securities class action lawsuit was filed in the United States District Court for the Southern District of New York against U.S. Physical Therapy, Inc. (NYSE: USPH).  The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market […]

The medical device maker St. Jude Medical played down the failure of some batteries in its defibrillators, shipping them for years before recalling the devices last fall, according to a warning letter the Food and Drug Administration issued this week.   The company, acquired by Abbott Laboratories in January, also failed to tell its own management and a medical advisory board that the battery problems had led to the death of a patient, the agency found.   The F.D.A. said St. Jude Medical had not shown it was taking sufficient action to fix the problems that led to the slow […]

Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against U.S. Concrete, Inc. Oklahoma City, OK (March 29, 2017) – On March 28, 2017, a securities class action lawsuit was filed in the United States District Court for the Northern District of Texas against U.S. Concrete, Inc. (NASDAQ: USCR). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class […]

Federman & Sherwood initiated litigation against Samsung Electronics America, Inc. and Samsung Electronics Co., Ltd. on January 13, 2017 on behalf of any and all consumers who have a Samsung home washing machines which have an inherently dangerous defect or suffer catastrophic failure during a given machine’s normal usage. Click here to see if you have a model number that is included in the litigation. If you have a recalled Samsung Washing Machine and wish to be included in the litigation, please complete the Contingent Fee Agreement by clicking here. You can return the executed Contingent Fee Agreement either by U.S. mail, email […]

To: All persons and/or entities who purchased common stock in Molycorp, Inc. [NYSE: MCP] during the period from February 21, 2012 through October 15, 2013, inclusive, and were damaged thereby; a settlement has been announced in the securities litigation known as In re Molycorp, Inc. Securities Litigation , Civil Action No. 13-Civ-5697 (PAC) , United States District Court for the Southern District of New York. For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed Settlement of Class Action and Settlement Fairness Hearing; Proof of Claim and Release. Claim […]

To: All persons and/or entities who purchased common stock in MARD, INC. f/k/a KIOR, INC. (“KIOR”) during the period from June 24, 2011 to March 17, 2014, and were damaged thereby; a settlement has been announced in the securities litigation known as Carlton, et al., v. Cannon, et al., Case No. 4:15-cv-00012 (S.D. Tex.), and the severed action Berry v. KiOR, Inc., et al., Case No. 4:13-cv-02443 (S.D.Tex.) (which was the name of the case when it was originally filed) (collectively, the “Actions”). For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed […]

To: All persons and/or entities who purchased common stock in KaloBios Pharmaceuticals, Inc. [NASDAQ: KBIO] during the period from November 18, 2015 to December 16, 2015, and were damaged thereby; a settlement has been announced in the securities litigation known as In re KaloBios Pharmaceuticals, Inc. Securities Litigation, Case No. 5:15-cv-05841, United States District Court for the Northern District of California.. For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed Settlement of Class Action and Settlement Fairness Hearing; Proof of Claim and Release. Claim submission deadline is April 6, 2017.  The […]

https://federmanlaw.publishpath.com/Websites/federmanlaw/images/Article-Securities_Law-An_Overview.pdf

What is the number one question we are asked by investors who contact our firm when a new securities case is filed? Why do securities class actions take so long to reach a settlement or reach some other type of resolution? Therefore, we decided to write this article to explain the lengthy process each and every securities lawsuit goes through before it ever reaches the point of a possible settlement. Click here to see the full article, which will hopefully answer questions you may have with respect to securities class actions. We hope to keep adding articles of interest to investors.

Investors in the stock market should know the purpose of a securities class action based upon fraud allegations, the underlying purpose for filing this type of litigation, and the rules governing such litigation.  Typical securities fraud class actions involve “alleged” misrepresentation during a specific period of time regarding a company’s operations, financial performance or future prospects that inflate the price of the company’s stock in secondary trading markets.  In these “fraud on the market” class actions, plaintiffs’ attorneys sue the corporation and its officers under Rule 10b-5 of the Securities Exchange Act of 1934, which was a huge, sweeping piece of legislation, but […]